Patheon has opened its new U.S. headquarters and analytical lab facilities in the vicinity of Research Triangle Park (RTP), NC. The new pharmaceutical development laboratory will support Patheon’s current U.S.-based pharmaceutical development operations in Cincinnati and will initially offer stability studies, validation testing and analytical chemistry services.

Wes Wheeler, chief executive officer and president of Patheon Inc., remarked, “North Carolina is a rapidly growing center for the pharmaceutical industry, which now boasts 334 biotechnology-related companies. It is a pro-business community which combines attractive corporate incentives with a high quality of life for our employees. We are delighted to open our new U.S. headquarters and our new laboratory here, in the vicinity of Research Triangle Park.”

The company recently announced that JLL Patheon Holdings, a holding company of private equity investors JLL Partners, is considering a bid to take Patheon private.